An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia. Issue 7 (12th April 2021) - Short, Nicholas J.; Konopleva, Marina; Kadia, Tapan; Kebriaei, Partow; Daver, Naval; Huang, Xuelin; Masarova, Lucia; Cook, Robin; Jain, Nitin; Jabbour, Elias; Kantarjian, Hagop; Ravandi, Farhad